We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$412M
AUM Growth
+$20.9M
Cap. Flow
-$6.64M
Cap. Flow %
-1.61%
Top 10 Hldgs %
58.04%
Holding
34
New
6
Increased
9
Reduced
14
Closed
4

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$33.1M
2
CVS icon
CVS Health
CVS
+$15.6M
3
MDT icon
Medtronic
MDT
+$8.17M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$7.4M
5
ALKS icon
Alkermes
ALKS
+$5.2M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$18.7M
2
BDX icon
Becton Dickinson
BDX
+$18.6M
3
BMY icon
Bristol-Myers Squibb
BMY
+$15.6M
4
CAH icon
Cardinal Health
CAH
+$9.9M
5
CTLT
CATALENT, INC.
CTLT
+$9.43M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
1
Medtronic
MDT
$106B
$35.8M 8.7%
435,075
+107,172
+33% +$8.17M
PFE icon
2
Pfizer
PFE
$143B
$31.5M 7.64%
+1,093,416
New +$33.1M
GILD icon
3
Gilead Sciences
GILD
$167B
$31M 7.52%
382,362
-240,761
-39% -$18.7M
BIIB icon
4
Biogen
BIIB
$30.4B
$26.5M 6.42%
102,234
-2,052
-2% -$504K
INCY icon
5
Incyte
INCY
$23.4B
$25M 6.07%
398,699
-33,846
-8% -$1.91M
BMY icon
6
Bristol-Myers Squibb
BMY
$124B
$19.2M 4.66%
374,687
-297,093
-44% -$15.6M
GEHC icon
7
GE HealthCare
GEHC
$28.7B
$19.1M 4.64%
247,531
+17,942
+8% +$1.26M
CVS icon
8
CVS Health
CVS
$137B
$17.3M 4.2%
+219,000
New +$15.6M
ZBH icon
9
Zimmer Biomet
ZBH
$17.6B
$17.2M 4.17%
141,218
-17,851
-11% -$1.99M
CAH icon
10
Cardinal Health
CAH
$53.5B
$16.6M 4.02%
164,305
-99,831
-38% -$9.9M
CNC icon
11
Centene
CNC
$32.8B
$16.1M 3.9%
216,416
-6,732
-3% -$486K
THC icon
12
Tenet Healthcare
THC
$16.8B
$14.6M 3.54%
193,279
+35,304
+22% +$2.24M
EW icon
13
Edwards Lifesciences
EW
$49.4B
$14.3M 3.47%
187,556
-25,439
-12% -$1.77M
ELV icon
14
Elevance Health
ELV
$80.9B
$13.1M 3.18%
27,807
-13,340
-32% -$6.17M
BAX icon
15
Baxter International
BAX
$11.7B
$12.7M 3.08%
328,132
+134,889
+70% +$4.77M
GMED icon
16
Globus Medical
GMED
$10.5B
$12.5M 3.03%
234,374
+12,547
+6% +$612K
LH icon
17
Labcorp
LH
$23.2B
$11.5M 2.8%
50,686
-14,171
-22% -$2.98M
BRKR icon
18
Bruker
BRKR
$8.86B
$9.35M 2.27%
127,312
+23,957
+23% +$1.54M
BMRN icon
19
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.32M 2.02%
86,247
-9,801
-10% -$867K
QGEN icon
20
Qiagen
QGEN
$8.49B
$8.28M 2.01%
179,689
+84,711
+89% +$3.6M
BIO icon
21
Bio-Rad Laboratories Class A
BIO
$8.15B
$7.62M 1.85%
+23,609
New +$7.4M
IONS icon
22
Ionis Pharmaceuticals
IONS
$8.99B
$7.34M 1.78%
145,012
-20,604
-12% -$987K
ALNY icon
23
Alnylam Pharmaceuticals
ALNY
$35.7B
$6.14M 1.49%
32,092
-20,876
-39% -$3.56M
ACAD icon
24
Acadia Pharmaceuticals
ACAD
$4.38B
$5.89M 1.43%
188,111
+8,326
+5% +$199K
ILMN icon
25
Illumina
ILMN
$28.2B
$5.65M 1.37%
+41,729
New +$4.81M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2023 Portfolio in Review

As of Q4 2023, Sector Gamma AS held 34 positions worth $412M, up 5.3% from $391M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Sector Gamma AS's Q4 2023 filing shows 6 new, 9 increased, 14 reduced and 4 closed positions. Its largest new stake was Pfizer: 1,093,416 shares worth $31.5M. The largest sale was Gilead Sciences, an estimated $18.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier, followed by Consumer Staples.

  • Sector Gamma AS's largest Q4 2023 buy was Pfizer: 1,093,416 shares worth $31.5M.
  • Sector Gamma AS added most to Medtronic in Q4 2023, an estimated $8.17M increase.
  • Sector Gamma AS's biggest Q4 2023 reduction was Gilead Sciences, cutting an estimated $18.7M.
  • Sector Gamma AS fully exited Becton Dickinson in Q4 2023, selling an estimated $18.6M.
  • Sector Gamma AS's ten largest holdings make up 58% of its $412M portfolio in Q4 2023.
  • Sector Gamma AS opened 6 new positions and closed 4 in Q4 2023.
  • Sector Gamma AS's portfolio value rose 5.3% quarter-over-quarter to $412M.

Based on Sector Gamma AS's 13F filing for Q4 2023, filed 5 Feb 2024.